ATHGX
Price
$26.05
Change
+$0.07 (+0.27%)
Updated
Aug 25 closing price
Net Assets
5.38B
RPMGX
Price
$102.15
Change
+$0.01 (+0.01%)
Updated
Aug 25 closing price
Net Assets
22.41B
Interact to see
Advertisement

ATHGX vs RPMGX

ATHGX vs RPMGX Comparison Chart in %
View a ticker or compare two or three
VS
ATHGX vs. RPMGX commentary
Aug 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHGX is a Hold and RPMGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 22.4B vs. ATHGX (5.38B). ATHGX (0.00) and RPMGX (0.00) have matching dividends . ATHGX was incepted earlier than RPMGX: ATHGX (9 years) vs RPMGX (34 years). ATHGX (0.80) and RPMGX (0.77) have similar cost to investors . ATHGX is a more actively managed with annual turnover of: 62.00 vs. RPMGX (31.50). ATHGX has a lower initial minimum investment than RPMGX: ATHGX (0) vs RPMGX (2500). RPMGX annual gain was more profitable for investors over the last year : -0.28 vs. ATHGX (-13.22). ATHGX (-19.45) and RPMGX (-20.39) have equivalent 5 years return.
ATHGXRPMGXATHGX / RPMGX
Total Expense Ratio0.800.77104%
Annual Report Gross Expense Ratio0.800.77104%
Fund Existence9 years34 years-
Gain YTD5.5945.039111%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets5.38B22.4B24%
Annual Yield % from dividends0.000.00-
Returns for 1 year-13.22-0.284,671%
Returns for 3 years13.614.39310%
Returns for 5 years-19.45-20.3995%
Returns for 10 yearsN/A32.01-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORMP5.210.39
+8.09%
Oramed Pharmaceuticals
CADL13.600.74
+5.75%
Candel Therapeutics
STT192.952.03
+1.06%
State Street Corp
SIM29.33-0.17
-0.58%
Groupo Simec SAB de CV
UPLD4.71-0.03
-0.63%
Upland Software